Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Cucchi

Orthopaedic Surgery of the Spine Orlando, FL Doctor of Osteopathy

NPI 1992839963 CMS profile 362416

3902 Millenia Blvd, Orlando, FL 32839

Open in the dashboard

General payments

$696,510

178 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anthony Cucchi of Orlando, FL is reported in the CMS Open Payments database as having received $696,510 across 178 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $116,943 15
2024 General $96,303 10
2023 General $96,354 18
2022 General $94,999 20
2021 General $93,335 21
2020 General $97,573 29
2019 General $101,003 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Cucchi
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Anthony Cucchi were reported at $116,943. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Anthony Cucchi Orthopaedic Surgery of the Spine median Middle half National median
2019 $101,003 $2,106 $337–$18,608 $163
2020 $97,573 $1,213 $156–$15,082 $114
2021 $93,335 $1,834 $271–$15,617 $132
2022 $94,999 $2,015 $320–$17,036 $149
2023 $96,354 $1,925 $336–$14,599 $160
2024 $96,303 $2,110 $341–$12,483 $164
2025 $116,943 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $515,977 116 payments
  2. Globus Medical, Inc. $105,222 24 payments
  3. VB Spine LLC $68,140 3 payments
  4. Cerapedics, Inc. $2,715 5 payments
  5. Alphatec Spine, Inc $2,479 6 payments
  6. Life Spine, Inc. $742 4 payments
  7. Boston Scientific Corporation $534 11 payments
  8. Smith+Nephew, Inc. $260 2 payments
  9. DePuy Synthes Sales Inc. $245 2 payments
  10. SI-BONE, Inc. $124 2 payments
  11. Other $74 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $591,628 49 payments
  2. Consulting Fee $86,375 23 payments
  3. Travel and Lodging $15,161 49 payments
  4. Food and Beverage $3,247 56 payments
  5. Education $99 1 payment
Products named General payments · program years 2019–2025
  1. EVEREST SPINAL SYSTEM $391,738 24 payments
  2. EVEREST $98,419 5 payments
  3. CREO ADDITION Spine/Spine Surgery $35,369 7 payments
  4. EVEREST XT $26,300 8 payments
  5. EVEREST MI $22,000 5 payments
  6. MANTIS $21,314 10 payments
  7. CREO Orthopedics/Orthopedic Surgery $21,261 4 payments
  8. CREO Addition Spine $17,536 5 payments
  9. CREO Spine $16,055 4 payments
  10. CREO Spine/Joint $15,000 4 payments
  11. Other $124,263 138 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

345

Median for Orthopedic Surgery: 203

Drug cost

$2,507

Median for Orthopedic Surgery: $1,433

Branded share of claims

33.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 88 $928
Baclofen Generic 95 $831
Ondansetron Hcl Generic 104 $458
Methylprednisolone Generic 31 $197
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 27 $93

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$243,482

Medicare's payments for the services billed

Medicare patients

287

Average age 74

Services billed

1,500

117 women, 170 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 37%
Chronic kidney disease 31%
Diabetes 30%
Depression 23%
Atrial fibrillation 22%
COPD 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record